Source comparison
Can You Take CJC-1295 No DAC Orally: Peptide vs Small-Molecule Comparison
Oral <2% (theoretical) 20–90% (typical) Proteolytic degradation N/A. Insufficient absorption Non-viable route for peptides Subcutaneous 90–95% 75–85% None (bypasses GI tract) 1–2 hours Standard route for peptide research Intravenous 100% None <5 minutes Reserv
This comparison does not assign a generated winner or score.
- Oral
- <2% (theoretical)
- 20–90% (typical)
- Proteolytic degradation
- N/A. Insufficient absorption
- Non-viable route for peptides
- Subcutaneous
- 90–95%
- 75–85%
- None (bypasses GI tract)
- 1–2 hours
- Standard route for peptide research
- Intravenous
- 100%
- None
- <5 minutes
- Reserved for clinical/hospital settings
- Intranasal
- 5–15% (experimental)
- 10–40%
- Mucosal enzymes + epithelial barrier
- 15–30 minutes
- Experimental only. Not validated for CJC-1295